Antibody Drug Conjugates Market Size | COVID-19 Impact Analysis | Forecast to 2027

The global antibody drug conjugates market is anticipated to grow at a considerable CAGR during the forecast period. The antibody-drug conjugates are a significant group of highly potent bio-pharmaceutical drugs that are designed as a targeted treatment for the healing of cancer patients.

The increasing prevalence of cancer is pushing the demand for antibody drug conjugates market. For instance, in 2017, in the US, 1,701,315 new cases were reported of cancer, and 599,099 people died due to the same. Every 100,000 people, 438 new cancer cases were reported and 153 people died due to that. In 2020, it was estimated that 1,806,590 new cases of cancer were diagnosed in the US and there were 606,520 mortalities due to the disease.

To Request a Sample of our Report on Antibody Drug Conjugates Market: https://www.omrglobal.com/request-sample/antibody-drug-conjugates-market

Moreover, the availability of a large product pipeline and the increasing trend of cost-effective and quality cancer treatment are other factors that are driving the global antibody drug conjugates industry.

Market Coverage

· The market number available for – 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

Segment Covered-

· By Application

· By Technology

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- AbbVie Inc., Astellas Pharma Inc., Bayer AG, Celldex Therapeutics, Inc., Creative Biolabs, Inc., ImmunoGen, Inc., Lonza Group, Pfizer Inc., Seattle Genetics, Inc.

Key Questions Addressed by the Report

· What is the market growth rate?

· Which segment and region dominate the market in the base year?

· Which segment and region will project the fastest growth in the market?

· How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

· Who is the leader in the market?

· How are players addressing challenges to sustain growth?

· Where is the investment opportunity?

(Get 15% Discount on Buying this Report)
A full Report of Antibody Drug Conjugates Market is Available at: https://www.omrglobal.com/industry-reports/antibody-drug-conjugates-market

Global Antibody Drug Conjugates Market Report Segment

By Application

· Blood Cancer

· Breast Cancer

· Ovarian Cancer

· Lung Cancer

· Others

By Technology

· Cleavable Linker

· Non-cleavable Linker

Global Antibody Drug Conjugates Market Report Segment by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· Rest of APAC

Rest of The World

· Latin America

· Middle East & Africa

Company Profiles

· AbbVie Inc.

· Astellas Pharma Inc.

· Bayer AG

· Celldex Therapeutics, Inc.

· Creative Biolabs, Inc.

· Genentech, Inc.

· Heidelberg Pharma AG

· ImmunoGen, Inc.

· Immunomedics, Inc.

· Lonza Group

· Mersana Therapeutics, Inc.

· Oxford BioTherapeutics Ltd.

· Pfizer Inc.

· Progenics Pharmaceuticals Inc.

· Seattle Genetics, Inc.

· Sorrento Therapeutics, Inc.

· Synthon Holding B.V.

· Takeda Pharmaceutical Co. Ltd.

Reasons for Buying from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antibody-drug-conjugates-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.